ARVD shows polymorphic expressivity with variable clinical expression of PKP2 mutations even among first-degree relatives ranging from a complete lack of symptoms to a severe disease phenotype experiencing sudden cardiac death (SCD)/right or biventricular heart failure. This evidence concerns the gene PKP2 and arrhythmogenic right ventricular cardiomyopathy.